Establishment of a novel human induced pluripotent stem cell line (SIPDi001-A) with compound heterozygous mutations in the UBR7 gene from a Li-Campeau syndrome patient
Summary
Li-Campeau syndrome (LICAS) is a syndromic neurodevelopmental disorder characterized by autosomal recessive inheritance and global developmental delay. In this study, we reported the generation of a novel induced pluripotent stem cell (iPSC) line derived from peripheral blood mononuclear cells (PBMCs) obtained from a 7-year-old male patient with Li-Campeau syndrome. The patient carries compound heterozygous variants in the UBR7 gene (c.35_54dup, p.S19Rfs*42; c.863 T > C, p.L288P). The iPSC line showed typical cell morphology, robust expression of pluripotent and self-renewal markers, normal karyotype, and trilineage differentiation potential. This iPSC cell line could be valuable for investigating the underlying pathological mechanisms of neurodevelopmental disorders caused by UBR7 mutations. Copyright © 2023 Affiliated Children\u0019s Hospital of Xi\u0019an Jiaotong University. Published by Elsevier B.V. All rights reserved.
| Authors | Li B, Zhou Y, Che F, Zhou R, Mo L, Zhang L, Wang G, Yang Y |
|---|---|
| Journal | Stem cell research |
| Publication Date | 2023 Sep;71:103165 |
| PubMed | 37478672 |
| DOI | 10.1016/j.scr.2023.103165 |